Patients were treated with MIPLYFFA in a 48-month open-label extension (OLE) study following the Phase 2/3, randomized, double-blind, placebo-controlled pivotal trial. The OLE data demonstrate that ...

Veteran tattoo artist Manjeet Singh spoke about the evolution of tattooing in India, its cultural acceptance, and the growing ...

The list for 2025 and several special awards were announced at a live ceremony in Macau, featuring bars from 20 destinations ...

Discover how IPG Health's REVEAL platform offers a cutting-edge solution for creating and presenting scientific posters with advanced features tailored to meet your needs.